Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINLESS: Ketorolac for Post-Craniotomy Pain
NCT04141319Phase 4Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ketorolac in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative doses of patient-controlled analgesia (PCA) butorphanol consumption from 0 to 48 h postoperatively. Status: unknown.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04141319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04141319.